These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus. Kurokawa M; Naito S; Ito S; Takai S; Kawamura Y; Kaneko H; Kakizaki H; Tsuchiya N IJU Case Rep; 2020 Sep; 3(5):181-183. PubMed ID: 32914068 [TBL] [Abstract][Full Text] [Related]
25. Isolated ACTH deficiency in a patient with empty sella as revealed by severe hyponatremia. Doroftei NA; de Rudder C; de Visscher N; Hanon F Acta Clin Belg; 2016 Dec; 71(6):451-454. PubMed ID: 27176077 [TBL] [Abstract][Full Text] [Related]
26. Durable response after the discontinuation of pembrolizumab treatment due to an adverse event in a patient with advanced endometrial cancer: A case report. Umihira S; Koyanagi T; Tamura K; Takahashi Y; Yoshiba T; Takahashi S; Taneichi A; Saga Y; Takei Y; Fujiwara H Exp Ther Med; 2022 Jun; 23(6):409. PubMed ID: 35619629 [TBL] [Abstract][Full Text] [Related]
27. Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial. Nishiyama H; Yamamoto Y; Sassa N; Nishimura K; Fujimoto K; Fukasawa S; Yokoyama M; Enokida H; Takahashi K; Tanaka Y; Imai K; Shimamoto T; Perini R; Frenkl T; Bajorin D; Bellmunt J Int J Clin Oncol; 2020 Jan; 25(1):165-174. PubMed ID: 31729625 [TBL] [Abstract][Full Text] [Related]
28. Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol. Liu Y; Zhang J; Yin Z; Zhu X; Xue L; Cao B Thorac Cancer; 2020 Jul; 11(7):2023-2030. PubMed ID: 32379397 [TBL] [Abstract][Full Text] [Related]
29. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab. Acero Brand FZ; Suter N; Adam JP; Faulques B; Maietta A; Soulières D; Blais N J Immunother Cancer; 2018 Mar; 6(1):22. PubMed ID: 29548299 [TBL] [Abstract][Full Text] [Related]